Pasireotide therapy of Multiple Endocrine Neoplasia type 1 (MEN1)-associated neuroendocrine tumours (NETs) improves survival and reduces tumour progression in a Men1+/- mouse model

The OCDEM Friday Seminar Series is supported by an unrestricted educational grant from the Boehringer-Ingelheim and Eli Lilly Alliance

Date: 15 January 2016, 12:45
Venue:
Churchill OCDEM 1
Headington OX3 7LE
See location on maps.ox

Details: Robert Turner Lecture Theatre
Speaker: Dr Mark Stevenson
Organising department: Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM)
Organiser: OCDEM Senior Academic Faculty (SAF)
Part of: OCDEM Friday Seminar Series
Topics:
Booking required?: Not required
Audience: Members of the University only
Editors: Sarah Cross, Matthew Simmonds